Emblok, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR (NCT07129421) | Emblok, Inc. | 2025-10-21 |
| Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR (NCT05295628) | Emblok, Inc. | 2023-10-17 |
Track Emblok, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.